Hirohumi Taji

418 total citations
8 papers, 269 citations indexed

About

Hirohumi Taji is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Hirohumi Taji has authored 8 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Hirohumi Taji's work include Lymphoma Diagnosis and Treatment (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Hirohumi Taji is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Hirohumi Taji collaborates with scholars based in Japan and France. Hirohumi Taji's co-authors include Yasuo Morishima, Eisei Kondo, Yoshitoyo Kagami, Yoshihisa Kodera, Yoshiki Akatsuka, Makoto Yazaki, Takashi Takahashi, Hiroatsu Iida, Kunio Tsujimura and Mikinori Miyazaki and has published in prestigious journals such as The Journal of Experimental Medicine, Transplantation and Bone Marrow Transplantation.

In The Last Decade

Hirohumi Taji

8 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hirohumi Taji Japan	7	161	84	74	67	54	8	269
Sotto Jj France	7	118 0.7×	68 0.8×	85 1.1×	78 1.2×	35 0.6×	30	237
S V Payne United Kingdom	8	173 1.1×	52 0.6×	65 0.9×	124 1.9×	55 1.0×	10	315
Catherine Spier United States	8	150 0.9×	169 2.0×	168 2.3×	48 0.7×	109 2.0×	10	384
Elena Sebastián Spain	9	92 0.6×	87 1.0×	82 1.1×	70 1.0×	55 1.0×	34	260
Zhihua Tian China	5	280 1.7×	169 2.0×	107 1.4×	54 0.8×	40 0.7×	8	404
Philip McCoy United States	5	260 1.6×	82 1.0×	194 2.6×	31 0.5×	93 1.7×	11	383
G. García-Manero United States	8	104 0.6×	139 1.7×	64 0.9×	80 1.2×	111 2.1×	24	329
Simanta Pathak United States	9	210 1.3×	62 0.7×	86 1.2×	31 0.5×	121 2.2×	12	371
Mark R. Krampf United States	5	112 0.7×	216 2.6×	61 0.8×	58 0.9×	44 0.8×	9	315
Jing Christine Ye United States	7	61 0.4×	82 1.0×	139 1.9×	35 0.5×	89 1.6×	20	262

Countries citing papers authored by Hirohumi Taji

Since Specialization

Citations

This map shows the geographic impact of Hirohumi Taji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirohumi Taji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirohumi Taji more than expected).

Fields of papers citing papers by Hirohumi Taji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirohumi Taji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirohumi Taji. The network helps show where Hirohumi Taji may publish in the future.

Co-authorship network of co-authors of Hirohumi Taji

This figure shows the co-authorship network connecting the top 25 collaborators of Hirohumi Taji. A scholar is included among the top collaborators of Hirohumi Taji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirohumi Taji. Hirohumi Taji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Itonaga, Hidehiro, Shuichi Ota, Takashi Ikeda, et al.. (2018). Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan. Leukemia Research. 75. 50–57. 19 indexed citations

Akatsuka, Yoshiki, Tetsuya Nishida, Eisei Kondo, et al.. (2003). Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens. The Journal of Experimental Medicine. 197(11). 1489–1500. 116 indexed citations

Akatsuka, Yoshiki, Eisei Kondo, Hirohumi Taji, et al.. (2002). Targeted cloning of cytotoxic T cells specific for minor histocompatibility antigens restricted by HLA class I molecules of interest1. Transplantation. 74(12). 1773–1780. 10 indexed citations

Kondo, Eisei, Michinori Ogura, Yoshitoyo Kagami, et al.. (2001). Assessment of Prognostic Factors in Follicular Lymphoma Patients. International Journal of Hematology. 73(3). 363–368. 17 indexed citations

Nakamura, Shigeo, Miyuki Kato, Koichi Ichimura, et al.. (2001). Peripheral T/Natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases. International Journal of Hematology. 73(1). 108–114. 22 indexed citations

Taji, Hirohumi, Yoshitoyo Kagami, Yoshimi Nishi, et al.. (1998). Growth Inhibition of CD20‐positive B Lymphoma Cell Lines by IDEC‐C2B8 Anti‐CD20 Monoclonal Antibody. Japanese Journal of Cancer Research. 89(7). 748–756. 63 indexed citations

Suzuki, Ritsuro, Hirohumi Taji, Shinsuke Iida, et al.. (1997). Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation. Bone Marrow Transplantation. 20(7). 615–617. 5 indexed citations

Taji, Hirohumi, et al.. (1996). Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.. PubMed. 3(11). 988–93. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact